About Company
The AlphaLife Sciences team is uniquely positioned to lead this category, combining world-class engineering talent—over 80% from Google, Verily, Microsoft, and Veeva—with deep domain expertise in pharma, regulatory writing, and clinical development. Our technical leadership is validated by formal selection into the technology programs of Microsoft, Google, NVIDIA, Veeva, and JLABS, as well as our role as Microsoft’s strategic AI content authoring partner for life sciences. This foundation enables the rapid, production-grade deployment of advanced AI—including RAG, agentic AI, and multi-agent systems—within a rigorously engineered, compliant platform already adopted by more than half of the global top-20 pharmaceutical companies. Backed by an advisory network that includes the former head of new drug review at the FDA, along with senior leaders from major pharma companies, CROs, and specialized life-sciences consultancies, the team consistently delivers enterprise-scale, regulatory-grade impact.
Vision, Mission, and Key Pillar Products
Our Vision is to accelerate global drug development—making it faster and more affordable through AI. Our Mission is to automate life-science content authoring and insight generation with AI, enabling biopharma teams to achieve greater efficiency, quality, and compliance. Our four pillar product lines, in both production and roadmap, are delivered through the AuroraPrime suite—a scalable, hyperscaler-powered GenAI platform built on Content Authoring, Content Insights, an AI Platform for Developers, and 360° Clinical Efficiency—together enabling true end-to-end drug lifecycle transformation.
Leadership Team
Sharon Chen
CEOFormer Director of Google R&D; Former General Manager of Verily APAC
Gavin Zhang
Chief Business OfficerFormer Head of Channel Sales Asia Pacific of Medidata; Former Key Account Solution Sales at Microsoft
Bogong Zhu
Chief Product OfficerFormer Senior Technical Supervisor at Google & Verily
Pengcheng Xu
Chief Technology OfficerEngineering Lead at Google; Former Engineering Architect at Verily
Advisory Board
John Jenkins
Former Director of Office of New Drugs at FDA. Former Principal of Drug and Biological Products at Greenleaf Health
Névine Zariffa
Board member of CDISC; Former SVP, Head of Biometrics & Information Sciences at AstraZeneca
Karen Devcich
Former Vice President, Medical Writing, Quality & Editing and Clinical Trial Transparency at ICON
Brand Story
In 2020, a group of senior technology and product experts from Google and Verily decided to start a business and delve into the intelligent digitalization of life science clinical research. With the goal of building a SaaS platform for life science and consumer health fields through world-leading computer technology, AlphaLife Sciences was officially established in August 2020. With the vision of "Use technology to advance innovation in life science and consumer health. Faster, more accessible and evidence-based," the AlphaLife team quickly grew and attracted many technology talents from leading global IT companies and senior industry experts from the life sciences field. With the gradual launch of AlphaLife's innovative products, more and more leading life science innovation and development companies, as well as ecosystem partners, choose AlphaLife, collaborate in multiple ways, and jointly explore the future of intelligent digitalization in clinical research.
Our global network and support
With experienced staff and trusted partners worldwide, we provide comprehensive support to ensure you have the resources you need, wherever you are.
-
New Jersey
-
San Francisco
-
Philadelphia
-
Singapore
-
Switzerland
-
Shanghai
Part of our investment partners
-
B Capital Group
-
Lightspeed China Partners
-
Hankang Capital